about
Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits.Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model.Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.Trimethylamine N-oxide: breathe new life.Anticoagulation increases alveolar hemorrhage in mice infected with influenza A.Ferric chloride-induced arterial thrombosis in mice.Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels.Procoagulant activity during viral infections.Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2.Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia.Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.Innate Effector-Memory T-Cell Activation Regulates Post-Thrombotic Vein Wall Inflammation and Thrombus Resolution.Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP)Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A miceAltered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP)The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient MiceThe parmodulin NRD-21 is an allosteric inhibitor of PAR1 Gq signaling with improved anti-inflammatory activity and stabilityA bacterial metabolite, trimethylamine N-oxide, disrupts the hemostasis balance in human primary endothelial cells but no coagulopathy in mice
P50
Q35105404-E621471E-DED9-412C-A0C6-5F7737B45487Q36414165-ED54C8B1-FAF3-4CBB-A32C-25A992E25B29Q39096019-1FB083AE-B313-440D-A166-72430321BA36Q39459129-25803089-017E-4D64-811D-A9F573DDCD17Q40399798-6F3AC1D5-BC7F-4871-841E-96BE4074EF02Q41341129-31EEEC46-0C2D-41B0-AD3C-0FFDD68B91C6Q41512070-D494AE00-8096-4AF0-8907-BED4D81B8666Q41933784-37EBA37D-78CD-44C7-92BA-436AF5B28271Q46357641-D35A3055-68EF-4D41-A4CC-9D2D6111B968Q47294887-9243F0CB-EA4A-427F-A836-6968098CFE47Q48211364-DA382873-EDA3-4C15-9A92-4253BF2AA3BCQ50619465-1D4F9893-2CE7-4463-ABD1-E55C2536147CQ86064091-F347183A-7795-4E2F-AE7D-C722E7B2CD25Q90083044-AB19F482-65AA-4B48-A5B0-F816C3008B62Q90751386-EB9B90DF-0412-48F9-835E-3700D74CAD4EQ90883502-FDADAED7-14BA-4BC7-9744-7AECBB9F1C29Q91999243-240F697C-F71D-44D2-B3A9-F7D705ECDD62Q93142869-E653C5B4-46B6-45D0-A345-2DD5CA1DC22B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Saravanan Subramaniam
@ast
Saravanan Subramaniam
@en
Saravanan Subramaniam
@es
Saravanan Subramaniam
@nl
Saravanan Subramaniam
@sl
type
label
Saravanan Subramaniam
@ast
Saravanan Subramaniam
@en
Saravanan Subramaniam
@es
Saravanan Subramaniam
@nl
Saravanan Subramaniam
@sl
prefLabel
Saravanan Subramaniam
@ast
Saravanan Subramaniam
@en
Saravanan Subramaniam
@es
Saravanan Subramaniam
@nl
Saravanan Subramaniam
@sl
P214
P106
P214
P31
P496
0000-0002-0194-5044
P7859
viaf-311449965